Hyundai Pharmaceutical Co., Ltd. (KRX:004310)
6,150.00
-440.00 (-6.68%)
Aug 7, 2026, 3:30 PM KST
60.16% (1Y)
| Market Cap | 170.22B +60.2% |
| Revenue (ttm) | 108.14B +5.8% |
| Net Income | 1.41B |
| EPS | 60.34 |
| Shares Out | 27.68M |
| PE Ratio | 101.93 |
| Forward PE | n/a |
| Dividend | 30.00 (0.49%) |
| Ex-Dividend Date | Mar 3, 2026 |
| Volume | 1,110,757 |
| Open | 6,610.00 |
| Previous Close | 6,590.00 |
| Day's Range | 6,030.00 - 6,650.00 |
| 52-Week Range | 3,500.00 - 15,960.00 |
| Beta | 0.70 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |